Posted inGenetics
Genomic Mapping of E. coli Capsules Identifies High-Risk Types for Vaccines
Credit: Sproetniek/ E+ / Getty Images A sweeping genomic survey is offering the clearest picture yet of how Escherichia coli…
Posted inBiotechnology
Merck, girding for Keytruda cliff, flies toward promising CML asset with $6.7B Terns acquisition
Merck and Terns Pharmaceuticals have agreed to a $6.7 billion all-cash buyout that delivers a prized leukemia asset to the…
Posted inBiotechnology
Sarepta’s big bet on Arrowhead’s siRNA assets yields early data
Sarepta Therapeutics has shared initial clinical data on two siRNA candidates, delivering an early look at the wisdom of its decision…
Posted inBiotechnology
Novo Nordisk prepares to go global as triple G prospect passes midphase diabetes test in China
Novo Nordisk and its Chinese partner have reported another midphase win for their triple G candidate, sharing diabetes data to add…
Posted inBiotechnology
BrightGene’s oral dual agonist sees up to 8% weight loss at 8 weeks in slice of early data
China’s BrightGene has served up a slice of early-stage data to remind everyone that it has a horse in the…
Posted inGenetics
Sanofi Steps Up Autoimmune Push with Up-to-$1.23B+ Kali Collaboration
Sanofi has agreed to license from Kali Therapeutics its lead tri-specific T-cell engager (TCE) antibody candidate KT501, which is being…
Posted inGenetics
Immunotherapy for Solid Tumors Enhanced by Metabolite-Sensing Receptors
Credit: nopparit / iStock / Getty Images In a new study published in Nature Immunology titled, “Engineering NK and T cells with…
Posted inGenetics
Glioblastoma Growth Mechanism Identified, Pointing to Potential Therapeutic Targets
Glioblastoma [Wikimedia Commons] A study led by Adelaide University scientists at the Centre for Cancer Biology (CCB) has uncovered a critical…
Posted inGenetics
Judge’s Halt on RFK Jr.’s Vaccine Changes Remains in Effect, At Least for Now
Pertussis cases in the U.S. have surged from roughly 7,000 in 2023 to over 35,000 in 2024, with at least…
Posted inResearch
Icon, Advarra partnership aims to optimize trials, expand access
Clinical research organization Icon has entered into a partnership with research technology company Advarra to launch a network of connected…